HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coronary Artery Disease (Coronary Atherosclerosis)

Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Also Known As:
Coronary Atherosclerosis; Arterioscleroses, Coronary; Artery Disease, Coronary; Artery Diseases, Coronary; Atheroscleroses, Coronary; Coronary Arterioscleroses; Coronary Artery Diseases; Coronary Atheroscleroses; Left Main Diseases; Arteriosclerosis, Coronary; Atherosclerosis, Coronary; Coronary Arteriosclerosis; Left Main Coronary Artery Disease; Left Main Coronary Disease; Left Main Disease
Networked: 43985 relevant articles (1668 outcomes, 8096 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Myocardial Infarction
2. Heart Failure
3. Stroke (Strokes)
4. Hypertension (High Blood Pressure)
5. Cardiovascular Diseases (Cardiovascular Disease)

Experts

1. Serruys, Patrick W: 236 articles (06/2022 - 06/2000)
2. Stone, Gregg W: 127 articles (10/2022 - 01/2004)
3. Kastrati, Adnan: 117 articles (10/2022 - 06/2002)
4. Park, Seung-Jung: 107 articles (10/2022 - 04/2002)
5. Li, Jian-Jun: 103 articles (01/2022 - 06/2004)
6. Angiolillo, Dominick J: 102 articles (11/2022 - 01/2005)
7. Nicholls, Stephen J: 97 articles (10/2022 - 10/2004)
8. Daida, Hiroyuki: 96 articles (10/2022 - 03/2002)
9. Bhatt, Deepak L: 94 articles (12/2022 - 04/2002)
10. Xu, Bo: 90 articles (04/2022 - 04/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Coronary Artery Disease:
1. LipidsIBA
2. Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
3. CholesterolIBA
4. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
5. oxidized low density lipoproteinIBA
6. LDL CholesterolIBA
7. Clopidogrel (Plavix)FDA Link
8. CalciumIBA
9. DobutamineFDA LinkGeneric
10. Sirolimus (Rapamycin)FDA Link

Therapies and Procedures

1. Therapeutics
11/01/2007 - "Current studies reconfirm that CABG is still the best therapy in terms of improved survival and freedom from reintervention for most patients with proximal left anterior descending, multivessel and left main-stem coronary artery disease (CAD) and that these benefits are even greater in diabetic patients. "
04/16/2013 - "This study evaluated data from 3 federally funded trials that focused on optimal medical therapy to determine if formalized attempts at risk factor control within clinical trials are effective in achieving guideline-driven treatment goals for diabetic patients with coronary artery disease (CAD). "
05/01/2020 - "Although history-based, electrocardiographic, and laboratory evaluations have shown promise in identifying coronary artery disease, early accurate diagnosis is paramount and there is an important role for imaging examinations to determine the presence and extent of anatomic coronary abnormality and ischemic physiology, to guide management with regard to optimal medical therapy or revascularization, and ultimately to thereby improve patient outcomes. "
01/01/2020 - "Patients with left main coronary artery disease have improved outcomes with coronary revascularization compared with medical therapy, but the choice of optimal revascularization technique is unresolved. "
11/01/1991 - "Diabetes is an important risk factor for late cardiac mortality after bypass surgery and should be included in analyses of the efficacy of therapies for coronary artery disease. "
2. Coronary Artery Bypass (Coronary Artery Bypass Surgery)
3. Stents
4. Percutaneous Coronary Intervention
5. Drug-Eluting Stents